» Articles » PMID: 12857776

Versatility of Aminoglycosides and Prospects for Their Future

Overview
Specialty Microbiology
Date 2003 Jul 15
PMID 12857776
Citations 216
Authors
Affiliations
Soon will be listed here.
Abstract

Aminoglycoside antibiotics have had a major impact on our ability to treat bacterial infections for the past half century. Whereas the interest in these versatile antibiotics continues to be high, their clinical utility has been compromised by widespread instances of resistance. The multitude of mechanisms of resistance is disconcerting but also illuminates how nature can manifest resistance when bacteria are confronted by antibiotics. This article reviews the most recent knowledge about the mechanisms of aminoglycoside action and the mechanisms of resistance to these antibiotics.

Citing Articles

Exploring molecular mechanisms of drug resistance in bacteria and progressions in CRISPR/Cas9-based genome expurgation solutions.

Vivekanandan K, Kumar P, Jaysree R, Rajeshwari T Glob Med Genet. 2025; 12(2):100042.

PMID: 40051841 PMC: 11883354. DOI: 10.1016/j.gmg.2025.100042.


The Global Challenge of : Antimicrobial Resistance and Emerging Intervention Strategies.

Bukari Z, Emmanuel T, Woodward J, Ferguson R, Ezughara M, Darga N Trop Med Infect Dis. 2025; 10(1).

PMID: 39852676 PMC: 11768457. DOI: 10.3390/tropicalmed10010025.


A brief insight into species - a growing threat to public health.

Jabeen I, Islam S, Hassan A, Tasnim Z, Shuvo S Front Antibiot. 2025; 2():1276982.

PMID: 39816660 PMC: 11731968. DOI: 10.3389/frabi.2023.1276982.


Phenotypic Differentiation Within the ' Aminoglycoside Resistance Gene Family Suggests a Novel Subtype IV of Contemporary Clinical Relevance.

Plattner M, Catelani M, Gmur S, Hartmann M, Kilic F, Haldimann K Antibiotics (Basel). 2025; 13(12.

PMID: 39766586 PMC: 11672645. DOI: 10.3390/antibiotics13121196.


Prevalence and virulence of Vibrio parahaemolyticus isolated from clinical and environmental samples in Huzhou, China.

Zhang P, Wu X, Ji L, Yan W, Chen L, Lu Z BMC Genomics. 2024; 25(1):1187.

PMID: 39639224 PMC: 11622476. DOI: 10.1186/s12864-024-11106-3.


References
1.
Kropec A, Lemmen S, Wursthorn M, Daschner F . Combination effect of meropenem with aminoglycosides and teicoplanin on Pseudomonas and enterococci. Infection. 1994; 22(4):306-8. DOI: 10.1007/BF01739926. View

2.
Biddlecome S, Haas M, Davies J, Miller G, Rane D, Daniels P . Enzymatic modification of aminoglycoside antibiotics: a new 3-N-acetylating enzyme from a Pseudomonas aeruginosa isolate. Antimicrob Agents Chemother. 1976; 9(6):951-5. PMC: 429656. DOI: 10.1128/AAC.9.6.951. View

3.
Roestamadji J, Mobashery S . The use of neamine as a molecular template: inactivation of bacterial antibiotic resistance enzyme aminoglycoside 3'-phosphotransferase type IIa. Bioorg Med Chem Lett. 1999; 8(24):3483-8. DOI: 10.1016/s0960-894x(98)00633-7. View

4.
Hachler H, Santanam P, Kayser F . Sequence and characterization of a novel chromosomal aminoglycoside phosphotransferase gene, aph (3')-IIb, in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1996; 40(5):1254-6. PMC: 163301. DOI: 10.1128/AAC.40.5.1254. View

5.
Moellering Jr R . The Garrod Lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. J Antimicrob Chemother. 1991; 28(1):1-12. DOI: 10.1093/jac/28.1.1. View